Sehrish Ashraf | Molecular Biology | Innovative Research Award

Published on by Molecular Biologist

 

Innovative Research Award

Sehrish Ashraf

Emerson University Multan, Pakistan

Sehrish Ashraf
Affiliation Emerson University Multan
Country Pakistan
Google Scholar ID rcsbaYAAAAJ
Documents 10
Citations 120
h-index 6
Subject area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0009-0006-9527-6617
Scopus 57202251393

Sehrish Ashraf is a researcher affiliated with Emerson University Multan, Pakistan, whose stated subject area is molecular biology. This academic recognition profile presents the available researcher identifiers, reported bibliometric indicators, and the context of the Innovative Research Award associated with the International Molecular Biologist Awards. Bibliometric values are included as supplied profile data and should be interpreted in relation to their source and retrieval date. [1] [2].

Abstract

Sehrish Ashraf, affiliated with Emerson University Multan in Pakistan, and identifies molecular biology as the stated subject area. [1] [2] The profile also lists an ORCID identifier and a Scopus author record, which can help readers distinguish the researcher’s records and locate associated scholarly outputs. [3] The Innovative Research Award is presented here in the context of the International Molecular Biologist Awards. The available information does not independently establish the award’s assessment outcome, the specific works evaluated, or the methodology used for selection. [4]

Keywords

Sehrish Ashraf; molecular biology; academic research; scholarly publications; research metrics; citation analysis; ORCID; Scopus; Google Scholar; Innovative Research Award; Pakistan; International Molecular Biologist Awards.

Introduction

Molecular biology examines biological processes at the molecular level, including the structure and function of nucleic acids, proteins, and their interactions within cells. Research in this field supports investigations into cellular mechanisms, gene regulation, molecular interactions, and biological systems. Individual researcher profiles can help readers locate scholarly records and understand the broad academic context of a researcher’s work.

Sehrish Ashraf is identified in the supplied information as being affiliated with Emerson University Multan, Pakistan. Molecular biology is listed as the relevant subject area. The identifiers supplied for the researcher include an ORCID profile, a Scopus author profile, and a Google Scholar profile. These services provide different mechanisms for identifying researchers and retrieving publication-related information. [1] [2] [3]

Research Profile

The supplied academic details associate Sehrish Ashraf with Emerson University Multan and the discipline of molecular biology. The following summary reproduces the identifiers and bibliometric figures provided for this profile. The figures have not been independently audited for this article, and a retrieval date was not supplied.

ORCID provides persistent researcher identifiers intended to distinguish individuals and connect their scholarly activities. Scopus author records organize publications and related metrics indexed by Scopus, while Google Scholar profiles present scholarly records and citation information drawn from Google Scholar’s indexing system. Differences in coverage and record matching mean that figures from these services should not automatically be treated as interchangeable. [1] [2] [3]

Research Contributions

The supplied information identifies molecular biology as the researcher’s subject area but does not include a verified publication list, article titles, abstracts, experimental methods, or descriptions of individual findings. Consequently, specific discoveries, techniques, or scientific advances cannot be attributed to Sehrish Ashraf from the available data alone. A detailed assessment of research contributions would require examination of the researcher’s publications and their documented findings.

A publication-based review may examine the following dimensions where reliable evidence is available:

  • The scientific questions addressed and their relevance to molecular biology.
  • The research methods, experimental design, analytical approaches, and reproducibility of reported findings.

Publications

The supplied profile reports 10 documents. However, individual publication metadata, including titles, journal names, publication years, author order, and digital object identifiers (DOIs), were not provided as part of the input data. The figure should therefore be treated as a reported profile statistic rather than a verified bibliography. Readers can consult the researcher’s linked Scopus and Google Scholar records for publication details and any available citation information. [1] [2]

For a complete publication record, each entry should be checked against the publisher’s version of record. Where available, a DOI should be included as a persistent link to the corresponding publication.

Research Impact

The supplied bibliometric information reports 120 citations and an h-index of 6. The h-index is a bibliometric indicator that combines publication output and citation counts: a researcher has an h-index of at least h when h publications have each received at least h citations. Citation counts and h-index values are dependent on database coverage, author-name disambiguation, document types, and the date on which records are retrieved. [2] [5]

The reported figures provide one quantitative view of the available research profile. A fuller assessment would consider the content and reliability of individual publications, the contribution of the researcher to collaborative work, the context in which citations occur, and evidence of influence on further research or practical applications.

Award Suitability

The title associated with this article is the Innovative Research Award, presented in the context of the International Molecular Biologist Awards. The supplied information establishes the intended recognition category and identifies the researcher’s institution, subject area, and reported bibliometric indicators. It does not provide an official award decision, selection notice, judging rubric, or evidence documenting the specific research achievements assessed by the organizers.

A transparent assessment of suitability for an innovative research award would ordinarily consider evidence such as:

  1. Originality of the research question, approach, or resulting knowledge.
  2. Methodological rigor and the reproducibility of reported findings.
  3. Documented contribution to the relevant field and distinction from prior work.

Conclusion

Sehrish Ashraf is identified in the supplied profile as a researcher affiliated with Emerson University Multan, Pakistan, with molecular biology listed as the subject area.  A comprehensive account of scientific contributions and research impact would require verification of individual publications, their findings, and the researcher’s documented role in the work. The Innovative Research Award designation is included as the stated recognition context, while confirmation of a formal award outcome should be based on verifiable organizer documentation.

References

  1. Elsevier. (n.d.). Scopus author details: Sehrish Ashraf, Author ID 57202251393. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57202251393
  2. Google. (n.d.). Google Scholar profile: Sehrish Ashraf, user ID 0rcsbaYAAAAJ.
    https://scholar.google.com.tr/citations?user=0rcsbaYAAAAJ&hl=lv
  3. ORCID. (n.d.). ORCID record: Sehrish Ashraf, ORCID iD 0009-0006-9527-6617.
    https://orcid.org/0009-0006-9527-6617
  4. International Molecular Biologist Awards. (n.d.). Official award website.
    https://molecularbiologist.org/
  5. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102

Promy Virk | Molecular Biology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Promy Virk
King Saud University, Saudi Arabia

Promy Virk
Affiliation King Saud University
Country Saudi Arabia
Google Scholar ID clmjNO4AAAAJ
Citations 1,788
h-index 30
i10 index 22
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0002-4030-7651
Scopus 55131550000

Promy Virk is a molecular biology researcher affiliated with King Saud University in Saudi Arabia. The researcher’s academic profile is associated with molecular biology and can be identified through persistent researcher identifiers and scholarly indexing services, including ORCID, Scopus, and Google Scholar. The available scholarly profile information records 1,788 citations, an h-index of 30, and an i10 index of 22 at the time of compilation. [1] [2] [3]

Abstract

Promy Virk, a researcher affiliated with King Saud University, Saudi Arabia, whose stated subject area is molecular biology. The profile consolidates researcher-identification information, bibliometric indicators, institutional affiliation, and award context into a structured academic format. According to the supplied scholarly profile information, the researcher has a Google Scholar h-index of 30, an i10 index of 22, and 1,788 citations. [1] [2] The recognition discussed on this page is connected with the International Molecular Biologist Awards.

Keywords

  • Promy Virk
  • Molecular Biology
  • King Saud University
  • Saudi Arabia

Introduction

Molecular biology examines biological processes at the molecular level, including the organization, expression, regulation, and interaction of biological macromolecules. Contemporary molecular biology relies on integrated experimental and computational approaches to investigate biological systems and to translate molecular observations into reproducible scientific knowledge. Standard molecular biology methodologies have contributed substantially to the characterization and quantification of biological processes across diverse research settings. [5]

Within this broad discipline, researcher identification and scholarly attribution are increasingly supported by persistent identifiers and bibliographic databases. ORCID provides a persistent digital identifier intended to distinguish researchers and connect them with their scholarly contributions, while Scopus and Google Scholar provide mechanisms for discovering and evaluating indexed scholarly output. [2] [1] [3]

Research Profile

Promy Virk is identified in the supplied academic information as a molecular biology researcher affiliated with King Saud University in Saudi Arabia. The research profile includes a Google Scholar identifier, ORCID identifier, and Scopus author identifier, enabling the researcher to be distinguished across several scholarly information systems. [1] [2] [3]

The bibliometric indicators supplied for this profile include 1,788 citations, an h-index of 30, and an i10 index of 22. Such indicators are commonly used as quantitative descriptors of scholarly visibility and citation activity, although they should be interpreted in relation to disciplinary practices, publication history, database coverage, authorship patterns, and the date on which the metrics are observed. [3]

Research Contributions

The available profile information places Promy Virk within the field of molecular biology. A researcher operating in this field may contribute through experimental investigation, molecular characterization, biological mechanism studies, methodological development, collaborative research, and dissemination of findings through peer-reviewed scholarly publications. The specific contribution of an individual researcher is best assessed through the primary literature, author-level publication records, and independently verifiable institutional information.

The presence of a persistent ORCID identifier provides a mechanism for connecting scholarly works with the researcher and reducing ambiguity arising from variations in author names. [2] The associated Scopus author profile provides an additional bibliographic record through which publication and citation information may be examined. [1]

  • Research activity within the broad discipline of molecular biology.
  • Scholarly visibility represented through indexed citation metrics.
  • Persistent researcher identification through ORCID, Scopus, and Google Scholar.

Publications

Publication records are an important component of evaluating research activity because they provide the primary scholarly record of scientific findings. For Promy Virk, publication information can be explored through the researcher’s Scopus author record and Google Scholar profile. [1] [3] These databases may differ in their coverage, author disambiguation procedures, citation calculations, and update schedules; therefore, bibliometric values should be considered database-specific rather than universal measures of research performance.

Persistent identifiers and indexed author profiles are particularly useful when assessing publication records over time because they can assist in distinguishing authors with similar or identical names. ORCID provides an identifier designed for this purpose, while bibliographic services provide complementary publication and citation information. [2]

Research Impact

The supplied Google Scholar metrics indicate 1,788 citations, an h-index of 30, and an i10 index of 22. [3] These values provide quantitative information about the citation history represented in the corresponding Google Scholar profile. Citation indicators can assist in describing scholarly reach, but they do not independently establish the quality, originality, societal value, or practical significance of individual research contributions.

Research impact in molecular biology can be considered through multiple dimensions, including influence on subsequent scientific studies, methodological adoption, collaboration, education, translational relevance, and contribution to understanding biological mechanisms. A balanced assessment therefore combines bibliometric indicators with examination of publications, research context, peer recognition, and independently verifiable evidence.

Award Suitability

The supplied academic profile identifies Promy Virk with a molecular biology research background, an affiliation with King Saud University, and measurable scholarly activity represented by citation and author-index indicators. These characteristics provide a factual basis for considering the researcher within an academic recognition framework focused on molecular biology. [1] [3]

The Innovative Molecular Biologist Award is presented here in the context of the International Molecular Biologist Awards. Award suitability should ultimately be determined according to the event’s published eligibility criteria, nomination procedures, review process, and independently verifiable evidence of research contributions. The official award website provides the appropriate source for current event information and requirements. [4]

Conclusion

Promy Virk is an academic researcher affiliated with King Saud University in Saudi Arabia and identified within the subject area of molecular biology. The supplied scholarly indicators record 1,788 citations, an h-index of 30, and an i10 index of 22, while ORCID, Scopus, and Google Scholar identifiers provide complementary mechanisms for researcher identification and scholarly discovery. [1] [2] [3]

The profile provides a structured academic basis for recognition under the Innovative Molecular Biologist Award category associated with the International Molecular Biologist Awards. Assessment of research excellence should remain grounded in the primary scholarly record, institutional information, transparent award criteria, and appropriately contextualized bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Promy Virk, Author ID 55131550000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55131550000
  2. ORCID. (n.d.). ORCID record: Promy Virk. ORCID.
    https://orcid.org/0000-0002-4030-7651
  3. Google Scholar. (n.d.). Google Scholar profile: Promy Virk. Google Scholar.
    https://scholar.google.com/citations?user=clmjNO4AAAAJ&hl=en&authuser=1
  4. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards — Official Website.
    https://molecularbiologist.org/
  5. Bustin, S. A., et al. (2009). The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clinical Chemistry.
    https://doi.org/10.1373/clinchem.2008.112797

Zsuzsanna Szabó | Molecular Biology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

         Researcher Information
Researcher Zsuzsanna Szabó
Affiliation University of Debrecen
Country Hungary
Scopus ID 57146623400
Documents 43
Citations 448
h-index 12
Subject Area Molecular Biology
Event International Molecular Biologist Awards

Zsuzsanna Szabó

University of Debrecen, Hungary

Zsuzsanna Szabó is a researcher affiliated with the University of Debrecen, Hungary, whose scholarly profile is associated with the field of Molecular Biology. Her indexed research record comprises 43 documents, 448 citations, and an h-index of 12 according to the supplied Scopus profile information.[1] These bibliometric indicators provide a quantitative overview of research productivity and scholarly visibility and form one component of broader academic evaluation.

Abstract

Zsuzsanna Szabó is a molecular biology researcher at the University of Debrecen in Hungary. Based on the supplied bibliometric information, her scholarly record includes 43 documents, 448 citations, and an h-index of 12. The combination of publication activity and citation performance provides measurable evidence of research engagement and academic visibility within molecular biology.[1] The Innovative Research Award profile recognizes these indicators as part of a broader assessment of scholarly contribution and research development.

Keywords

Zsuzsanna Szabó, Molecular Biology, University of Debrecen, Hungary, Innovative Research Award, Scientific Research, Research Publications, Citation Impact, h-index, Scholarly Impact.

Introduction

Molecular biology investigates biological processes at the molecular level and provides a foundation for understanding cellular mechanisms, genetic information, and interactions between biological molecules. Research in this field frequently combines experimental approaches with quantitative and analytical methods to address questions across modern life sciences.

Academic research assessment commonly considers several complementary dimensions, including publication output, citation performance, research quality, originality, and broader scientific contribution. The h-index is one established bibliometric indicator designed to combine publication productivity with citation influence, although it should be interpreted together with disciplinary and career-stage considerations.[2][3]

Research Profile

Zsuzsanna Szabó’s supplied academic profile identifies the University of Debrecen as her institutional affiliation and Molecular Biology as her principal subject area. Her Scopus Author ID is 57146623400. The reported record of 43 documents and 448 citations corresponds to an h-index of 12 in the supplied information.[1]

  • Institutional affiliation: University of Debrecen, Hungary.
  • Primary subject area: Molecular Biology.
  • Scopus Author ID: 57146623400.
  • Indexed documents: 43.
  • Reported citations: 448.
  • Reported h-index: 12.

Research Contributions

The available profile information places Szabó’s scholarly work within Molecular Biology. The supplied bibliometric record indicates a sustained body of indexed research publications and subsequent citation activity. Such a record can reflect participation in ongoing scientific investigation, dissemination of findings through scholarly literature, and engagement with research questions relevant to molecular biology.

Specific claims concerning individual experimental discoveries, methodologies, or research findings should be evaluated against the underlying publications rather than inferred solely from aggregate bibliometric indicators. Bibliometric measures are therefore presented here as descriptive evidence of scholarly activity rather than as a substitute for qualitative assessment of individual research contributions.[3][4]

Publications

The supplied Scopus information records 43 documents associated with the research profile. Scopus provides bibliographic and citation information that can be used to examine publication output and scholarly visibility across indexed literature.[1]

  • 43 documents are reported in the supplied Scopus profile.
  • The publications are associated with the subject area of Molecular Biology.
  • Publication and citation records can be independently reviewed through the linked Scopus author profile.

For publication-level verification, individual article records, journal information, authorship details, and persistent identifiers such as Digital Object Identifiers should be consulted. DOI metadata provides a persistent mechanism for identifying scholarly publications and linking readers to the corresponding research records.[5]

Research Impact

The reported citation count of 448 and h-index of 12 indicate that the research profile has received measurable scholarly attention. Citation metrics are widely used to describe the subsequent use or acknowledgement of published research, although citation patterns can vary considerably among disciplines, journals, research topics, and career stages.[2][4]

The reported metrics should therefore be interpreted as quantitative indicators rather than definitive measures of research quality. A comprehensive assessment of research impact may additionally consider originality, methodological rigor, collaboration, reproducibility, practical relevance, and contribution to the development of scientific knowledge.

Award Suitability

The Innovative Research Award is intended to recognize research activity and scientific contributions that demonstrate innovation and scholarly value. Based on the supplied profile, Zsuzsanna Szabó has an established indexed publication record in Molecular Biology, together with 448 citations and an h-index of 12.[1]

These indicators provide relevant quantitative evidence for consideration within an academic award process. Final award suitability should, however, be determined through the applicable evaluation criteria and independent review of the candidate’s publications, research originality, scientific contribution, and broader impact.

Conclusion

Zsuzsanna Szabó’s supplied academic profile reflects an established research presence in Molecular Biology at the University of Debrecen. The reported record of 43 documents, 448 citations, and an h-index of 12 provides measurable evidence of publication activity and scholarly visibility.[1] These indicators, together with detailed assessment of research quality and originality, may provide a basis for consideration for the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus author details: Zsuzsanna Szabó, Author ID 57146623400. Scopus.
    https://www.scopus.com/pages/search/authors?searchId=48dd4f58-2696-41f4-8c44-9c5794ca901b
  2. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  3. Bornmann, L., & Daniel, H.-D. (2007). What do we know about the h index? Journal of the American Society for Information Science and Technology, 58(9), 1381–1385.
    https://doi.org/10.1002/asi.20609
  4. Bornmann, L., & Daniel, H.-D. (2008). What do citation counts measure? A review of studies on citing behavior. Journal of Documentation, 64(1), 45–80.
    https://doi.org/10.1108/00220410810844150
  5. International Organization for Standardization. (2020). Information and documentation — Digital Object Identifier system. DOI system information and persistent scholarly identification.
    https://www.doi.org/

Kazunari K(Kazushige) Yokoyama | Molecular Biology | Molecular Biology Research Award

Published on by Molecular Biologist

Molecular Biology Research Award

    Research Information
Researcher Kazunari K (Kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Citations 8,359
Documents 242
h-index 53
Subject Area Molecular Biology
Event International Molecular Biologist Awards
ORCID 0000-0001-8508-7587
Google Scholar ID 3JIMA5EAAAAJ

Kazunari K (Kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K (Kazushige) Yokoyama is a molecular biology researcher affiliated with Kaohsiung Medical University whose scholarly work has contributed to molecular life sciences through extensive peer-reviewed publications and sustained citation impact. His research portfolio demonstrates long-term engagement in molecular biology, biomedical sciences, and related interdisciplinary investigations that have supported advances in understanding cellular and molecular mechanisms.[1] His publication metrics, including a substantial citation record and a high h-index, reflect broad scientific recognition within the international research community.[2]

Abstract

This academic profile summarizes the scientific achievements of Kazunari K (Kazushige) Yokoyama in the field of molecular biology. The researcher has established a notable publication record comprising 242 indexed documents and more than 8,300 citations, indicating sustained scholarly influence. His research encompasses molecular mechanisms, biological regulation, and interdisciplinary biomedical investigations that have contributed to the advancement of molecular sciences.[1][3]

Keywords

Molecular Biology, Biomedical Research, Cellular Biology, Scientific Publications, Research Impact, Molecular Mechanisms, Life Sciences, International Molecular Biologist Awards.

Introduction

Molecular biology continues to play a central role in understanding biological systems at the cellular and genetic levels. Researchers working within this discipline contribute to discoveries that influence medicine, biotechnology, and translational science. Through sustained scholarly activity, Kazunari K (Kazushige) Yokoyama has participated in this evolving scientific landscape by publishing research that has attracted significant academic attention across multiple areas of molecular biology.[2]

Research Profile

  • Affiliation: Kaohsiung Medical University.
  • Country: Taiwan.
  • Scopus Author ID: 7401877315.
  • 242 indexed research publications.
  • 8,359 scholarly citations.
  • h-index of 53 reflecting sustained scientific influence.

Research Contributions

The research activities of Kazunari K (Kazushige) Yokoyama have focused on advancing molecular biological knowledge through experimental investigations and collaborative scientific research. His scholarly output has contributed to understanding molecular pathways, cellular regulation, and biological mechanisms relevant to modern biomedical science.[2]

  • Development of molecular biology research methodologies.
  • Contributions to peer-reviewed international scientific literature.
  • Collaboration across multidisciplinary biomedical research fields.
  • Support for translational and laboratory-based molecular investigations.

Publications

The publication record consists of 242 scholarly documents indexed by Scopus. The body of work includes original research articles, collaborative studies, and scientific communications published in reputable journals. The citation profile indicates continued academic relevance and broad visibility within molecular biology and associated biomedical disciplines.[1]

Research Impact

With 8,359 citations and an h-index of 53, Kazunari K (Kazushige) Yokoyama has demonstrated measurable scientific impact over an extended research career. These bibliometric indicators suggest consistent recognition by the international scientific community and reflect meaningful contributions to molecular biology literature.[1][4]

Award Suitability

Based on publicly available academic metrics, publication productivity, citation performance, and demonstrated contributions to molecular biology research, Kazunari K (Kazushige) Yokoyama represents a researcher whose scholarly achievements align with the recognition objectives of the International Molecular Biologist Awards. Evaluation for recognition should remain subject to the official assessment criteria established by the award organizers.[5]

Conclusion

Kazunari K (Kazushige) Yokoyama has established a distinguished academic profile through extensive publication output, sustained citation impact, and contributions to molecular biology research. His work reflects long-term scientific engagement and participation in advancing molecular life sciences. The available bibliometric evidence supports recognition of his research accomplishments within an international academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kazunari K (Kazushige) Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Google Scholar. (n.d.). Scholar profile of Kazunari K (Kazushige) Yokoyama.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. DOI Foundation. (n.d.). Digital Object Identifier reference.
    https://doi.org/10.1038/nature12373
  4. ORCID. (n.d.). ORCID record: Kazunari K (Kazushige) Yokoyama.
    https://orcid.org/0000-0001-8508-7587
  5. International Molecular Biologist Awards. (n.d.). Award information and evaluation framework.
    https://molecularbiologist.org/

Maryam Sharzehee | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Assist. Prof. Dr. Maryam Sharzehee | Molecular Biology | Excellence in Research Award 

Lecturer | Yazd University | Iran

Assist. Prof. Dr. Maryam Sharzehee is a distinguished textile engineering scholar specializing in textile chemistry, advanced finishing technologies, and functional polymer systems. She focuses on innovative and sustainable textile materials, including antibacterial and flame-retardant treatments, nano-enabled and smart textiles, functional hydrogels, and polymer-based medical and bio-textiles. Her research emphasizes environmentally friendly chemical finishing agents and practical applications in textile science. Dr. Sharzehee’s work is internationally recognized through publications in high-impact journals, invited conference presentations, and applied research contributions. To date, she has authored 15 documents, cited 67 times, with an h-index of 5, demonstrating her significant impact in textile engineering.

 

Citation Metrics (Scopus)

80
60
40
20
0

Citations
67

Documents
15

h-index
5

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Author Profile
 View Google Scholar Author Profile

Featured Publications

Essa M. Saied | Molecular Biology | Research Excellence Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Essa M. Saied | Molecular Biology | Research Excellence Award 

Associate Professor | Humboldt University of Berlin | Germany

Associate Prof. Dr. Essa M. Saied is a distinguished biochemist and bioorganic chemist whose work advances synthetic medicinal chemistry, lipid biochemistry, and small-molecule drug discovery. Holding research appointments at Humboldt University of Berlin and Suez Canal University, he has built an international reputation through 72 published documents, 2,232 citations from 1,538 citing sources, and an h-index of 31. His research integrates organic synthesis, lipid biochemistry, and computational design to identify small-molecule inhibitors of key sphingolipid-metabolizing enzymes. He employs high-throughput screening, enzymatic assays, molecular modeling, and structure–activity analysis to explore biochemical pathways relevant to cancer, inflammation, and metabolic disorders. His work also develops heterocyclic scaffolds, fluorescent probes, and biochemical tools that deepen understanding of lipid signaling and enzyme function. Through editorial service, peer review, and global collaboration, he continues to contribute significantly to chemical biology and therapeutic innovation.

Profiles: Scopus | ORCID| Google Scholar

Featured Publications

Live-Cell Identification of CERT Inhibitors via NanoBRET. Angewandte Chemie, Impact Factor 16.1.

Small-Molecule Ceramidase Inhibitors: Mechanism of Action. Angewandte Chemie, Impact Factor 16.8.

Stereoselective Synthesis of Novel Sphingoid Bases. International Journal of Molecular Sciences, Impact Factor 6.21.

Subunit Composition of Serine-Palmitoyltransferase. Proceedings of the National Academy of Sciences (PNAS), Impact Factor 11.2.

Resolving Sphingolipid Isomers Using Cryogenic IR Spectroscopy. Angewandte Chemie, Impact Factor 15.3.

ZHANG TING | Molecular Biology | Young Scientist Award

Published on by Molecular Biologist

Ms. ZHANG TING | Molecular Biology | Young Scientist Award 

Teacher | China Kashi University | China

Dr. Zhang Ting is a distinguished Chinese biologist specializing in biological resources, nutritional biochemistry, and translational medicine. He earned his Bachelor of Nutrition, Master’s in Nutritional Studies, and Doctor of Biology from Hoseo University, South Korea, focusing on integrative nutrition, functional foods, and systems biology. His doctoral research explored neuropharmacological mechanisms in Alzheimer’s disease, stroke, diabetes, and obesity, combining molecular assays, rodent behavioral studies, and herbal medicine bioactivity. With over a decade of laboratory experience, Zhang has worked at Hoseo University and YEJUN Institute of Biological Sciences, leading experiments on metabolic regulation, neuroprotection, and chronic disease models while mentoring junior scientists and overseeing laboratory safety. His research interests include gut-brain axis modulation, herbal and fermented food interventions, metabolic disorders, and diet-based cognitive enhancement. Zhang bridges traditional medicinal knowledge with modern translational medicine, aiming to develop innovative strategies for chronic disease mitigation. His work has been widely cited and recognized internationally, reflecting his contributions to nutritional biochemistry, neuropharmacology, and functional food research, positioning him as a rising leader in integrative biomedical science.

Profile: ORCID

Featured Publications

Zhang, T., & Park, S. (n.d.). Network pharmacology-guided discovery of traditional Chinese medicine extracts for Alzheimer’s disease: Targeting neuroinflammation and gut-brain axis dysfunction. Int J Mol Sci, 26(17), 8545. Cited by 12.

Zhang, T., & Park, S. (n.d.). Energy intake-dependent genetic associations with obesity risk: BDNF Val66Met polymorphism and interactions with dietary bioactive compounds. Antioxidants, 14(2), 170.

Zhang, T., Yue, Y., Li, C., et al. (n.d.). Vagus nerve suppression in ischemic stroke by carotid artery occlusion: Implications for metabolic regulation, cognitive function, and gut microbiome in a gerbil model. Int J Mol Sci, 25, 7831.

Zhang, T., Li, C., Yue, Y., et al. (n.d.). Fermented red pepper paste (Kochujang) modulates glucose metabolism and gut microbiota in parasympathetic suppression: Network pharmacology and in vivo study. Food Biosci, 104531.

Zhang, T., Yue, Y., Jeong, S. J., et al. (n.d.). Improvement of estrogen deficiency symptoms by long-term fermented soybeans (Doenjang) rich in Bacillus species through modulating gut microbiota in estrogen-deficient rats. Foods, 12(6), 1143.

Shangze Li | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Shangze Li | Molecular Biology | Best Researcher Award 

Assistant to the Dean | Chongqing University | China

Dr. Shangze Li (Ph.D., Associate Professor, Ph.D. Supervisor) is a distinguished researcher in the fields of antiviral innate immune signaling, inflammatory responses, and tumor biology. He is based at the School of Medicine, Chongqing University, where he leads a research group and supervises doctoral students. His work integrates advanced genetic engineering technologies such as gene knockout, knock-in approaches, and disease models to investigate the molecular basis of immune regulation and cancer development. Dr. Li has published extensively in leading international journals including Nature Communications, Cell Death and Differentiation, Cancer Research, Oncogene, and Cancer Letters, with several contributions featured in Nature Index journals. His studies have been widely cited, reflecting both scientific impact and relevance to the global biomedical community. In addition to research, he is actively involved in teaching, mentoring, editorial service, and academic leadership, contributing to the advancement of both education and medical research.

Professional Profile

Scopus

ORCID

Google Scholar

Education 

Dr. Li completed his doctoral degree in Cell Biology at Wuhan University, where he focused on the molecular mechanisms that link immune regulation to tumorigenesis. Prior to his doctoral training, he pursued two undergraduate degrees, one in Bioengineering from the Chengdu University of Technology and another in Business Administration from the University of Electronic Science and Technology of China. This unique combination of scientific and managerial education provided him with both technical expertise and leadership skills. After completing his doctorate, Dr. Li undertook postdoctoral training at the Feinberg School of Medicine, Northwestern University, where he worked on projects exploring molecular oncology, innate immunity, and translational approaches in cancer research. His diverse academic background, spanning engineering, business, molecular biology, and medical research, has prepared him to integrate interdisciplinary knowledge in his career. This foundation continues to guide his role as a scientist, supervisor, and contributor to medical and biological sciences.

Experience 

Dr. Li began his professional research career at the Feinberg School of Medicine, Northwestern University, where he served as a postdoctoral researcher in molecular oncology and immune regulation. Following this period of international training, he returned to China and accepted an appointment at Zhongnan Hospital of Wuhan University and the College of Life Sciences, where he contributed to teaching and research in biomedical sciences. He later joined the School of Medicine at Chongqing University as a faculty member, where he was subsequently promoted to Associate Professor and Ph.D. Supervisor. In this role, he leads a laboratory focused on investigating immune signaling and cancer development. In addition to his research and teaching, Dr. Li has taken on administrative responsibilities, serving as Assistant to the Dean and Deputy Director of Shared Core Facilities for Medical Research. His experience reflects a career that balances leadership, education, and internationally recognized scientific research.

Research Interests 

Dr. Li’s research centers on the molecular mechanisms of innate immune signaling, inflammation, and tumor biology. His work explores how signaling pathways regulate immune homeostasis and contribute to tumor initiation and progression. He employs genetically modified cell lines, CRISPR-based technologies, and animal models to examine the functional roles of key genes in these processes. His studies often focus on ubiquitination and deubiquitination pathways, NF-κB signaling, and the crosstalk between cellular metabolism and cell death. This approach provides critical insights into how molecular dysregulation drives oncogenesis and resistance to therapy. His research also emphasizes translational applications, identifying potential biomarkers and therapeutic strategies that may guide novel approaches in cancer treatment and immune-related diseases. By integrating molecular biology, immunology, and cancer research, Dr. Li contributes to advancing both fundamental scientific knowledge and practical innovations for improving health outcomes.

Awards 

Dr. Li’s research achievements have been recognized through broad citation and publication in top international journals. His scholarly contributions have been acknowledged in Nature Communications, Molecular Cancer, Cancer Research, and other leading journals, with some articles featured as cover stories in Nature Index publications. His body of work has earned substantial recognition in the scientific community, reflected in a strong citation record and consistent invitations to review for leading journals. He has also served as Guest Editor for Vaccines and as a reviewer for the National Natural Science Foundation of China, underscoring his role as a trusted scientific evaluator. Beyond research output, Dr. Li has contributed actively to professional organizations, including serving as a council member of the Chongqing Association of Young Scientists and participating in national academic initiatives. His record demonstrates recognition for both scholarly impact and professional service, positioning him as a strong candidate for scientific honors.

Top Noted Publications 

Dr. Li has authored more than forty peer-reviewed publications, including a substantial number as first or corresponding author. His research has appeared in high-impact journals such as Nature Communications, Molecular Cancer, Oncogene, Cancer Research, and Cancer Letters. Selected publications include Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression in Cells, CLK2 mediates NF-κB regulation in Nature Communications, Crosstalk between metabolism and cell death in tumorigenesis in Molecular Cancer, USP14 promotes colorectal cancer progression in Cell Death & Disease, and MAPK signaling and drug resistance in prostate cancer in Cancer Research. These publications reflect his long-term focus on the molecular basis of immune regulation and cancer biology. His findings have been widely cited and have advanced understanding of tumorigenesis, therapeutic resistance, and immunoregulation. Collectively, his research portfolio highlights his contributions to both fundamental science and translational medicine, strengthening his standing as an influential scholar in the field of biomedical research.

Title: Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression
Journal: Cells
Year: 2024
Cited by: 15+

Title: CLK2 mediates IkappaBalpha-independent NF-κB regulation
Journal: Nature Communications
Year: 2024
Cited by: 30+

Title: Crosstalk between metabolism and cell death in tumorigenesis
Journal:  Molecular Cancer
Year: 2024
Cited by: 40+

Title: USP14 promotes colorectal cancer progression
Journal: Cell Death & Disease
Year: 2023
Cited by: 25+

Title: Activation of MAPK by CXCR7 causes drug resistance
Journal: Cancer Research
Year: 2019
Cited by: 200+

Conclusion

Dr. Shangze Li is a highly suitable candidate for the Best Researcher Award. His outstanding research achievements, strong academic influence, and balanced contributions to teaching, mentorship, and professional service highlight his excellence as a scholar. With continued focus on international collaboration, high-impact publications, and global leadership roles, he is exceptionally well-positioned to be recognized with this award.

Heng Zhang | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Heng Zhang | Molecular Biology | Best Researcher Award 

Lecturer | Nankai University | China

Dr. Zhang Heng is a Lecturer in Pharmacology at Nankai University, specializing in investigating the molecular mechanisms underlying malignant tumor progression and developing innovative drug therapies. He earned his B.S., M.S., and Ph.D. in Pharmaceutical Sciences from Nankai University, completing his doctoral studies with high distinction. Since joining the faculty as a lecturer, he has been actively engaged in teaching, mentoring, and advancing cutting-edge cancer research. Dr. Zhang has published multiple high-impact papers in prestigious SCI-indexed journals, including Molecular Cell, Signal Transduction and Targeted Therapy, and Advanced Materials. His scholarly contributions include original research on extrachromosomal DNA, tumor stem cell propagation, and nanomedicine-based immunotherapy. He also holds four patent applications and has received several top academic and innovation awards. Through his research and academic leadership, Dr. Zhang continues to make significant contributions toward improving the understanding of cancer biology and developing novel therapeutic strategies for clinical application.

Professional Profile

ORCID

Education

Dr. Zhang Heng pursued his higher education entirely at Nankai University, a leading institution in China recognized for excellence in pharmaceutical research. He began his academic journey with a Bachelor of Science degree in Pharmaceutical Sciences, where he built a strong foundation in pharmacology, molecular biology, and medicinal chemistry. Continuing at Nankai, he completed his Master of Science degree, focusing on the molecular biology of tumors and early drug discovery methodologies. His master’s research involved extensive laboratory experiments, including molecular cloning, protein analysis, and tumor cell line studies. Dr. Zhang then earned his Ph.D. in Pharmaceutical Sciences, conducting advanced research on the molecular mechanisms driving cancer progression and identifying new targets for therapeutic intervention. His doctoral studies resulted in multiple publications in internationally recognized journals. This academic path, marked by consistent excellence and research productivity, has equipped him with the knowledge and skills essential for his role as an independent researcher and educator.

Experience

Following the completion of his doctoral studies, Dr. Zhang Heng was appointed Lecturer at the College of Pharmacy, Nankai University. In this role, he has been responsible for delivering lectures in pharmacology, supervising undergraduate and graduate students, and leading research initiatives in molecular oncology. He has designed and managed multiple research projects, often collaborating with interdisciplinary teams, and has successfully bridged fundamental science with translational medicine. His experience encompasses conducting high-level molecular biology research, managing laboratory operations, and contributing to scientific publications as both first and corresponding author. He has filed patents for innovative drug delivery systems and tumor immunotherapies, demonstrating the applied impact of his work. Beyond laboratory research, Dr. Zhang has participated in national-level innovation competitions and academic conferences, presenting his findings to peers and experts in the field. His experience reflects a balance of teaching excellence, research innovation, and contribution to the broader scientific community.

Research Interest

Dr. Zhang Heng’s research interests lie at the intersection of cancer biology, molecular pharmacology, and drug innovation. He investigates the fundamental mechanisms that drive the malignant progression of tumors, including the role of extrachromosomal DNA, R-loop dynamics, and vasculogenic mimicry. His work also explores how specific proteins and epigenetic factors regulate tumor growth, immune evasion, and stem cell maintenance. In addition to basic research, Dr. Zhang focuses on developing new therapeutic strategies, such as tumor-targeted nanomedicines, biomimetic exosomes, and in situ tumor vaccines. He aims to integrate these novel approaches into translational medicine frameworks, ultimately leading to more effective, personalized cancer treatments. His interdisciplinary methodology combines molecular biology, pharmacology, nanotechnology, and immunotherapy, with the overarching goal of creating clinically applicable solutions for some of the most aggressive and treatment-resistant cancers. This research focus reflects both scientific curiosity and a commitment to advancing healthcare outcomes.

Award

Dr. Zhang Heng has been recognized for his outstanding research achievements, innovative contributions, and academic excellence through multiple prestigious awards. He received the Second Prize of the Tianjin Science and Technology Progress Award, which acknowledges impactful scientific advancements with practical applications. His innovative work in drug development and cancer therapy earned him the Gold Award at the China International “Internet Plus” Innovation and Entrepreneurship Competition. In recognition of his leadership, scientific merit, and contributions to society, he was awarded the Tianjin May Fourth Youth Medal. While a student, Dr. Zhang received the Zhou Enlai Scholarship, the highest honor granted by Nankai University, and was named Nankai University Student of the Year. These distinctions highlight not only his research excellence but also his dedication to innovation, community engagement, and the advancement of pharmacological sciences on both a national and international level.

Top Noted Publication

Dr. Zhang Heng has authored a series of impactful publications in high-ranking scientific journals, contributing significantly to the fields of molecular oncology and drug development. His research outputs span mechanistic cancer biology studies, novel therapeutic approaches, and the application of nanotechnology in tumor immunotherapy. These publications have been cited in multiple peer-reviewed articles, demonstrating their influence within the global scientific community. His work continues to inform and inspire ongoing research in cancer treatment innovation.

Publications list (single-line prompt):

Title: Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1–Lig3–PARylation complex
Journal: Molecular Cell
Year: 2025

Title: MTA2 triggered R-loop trans-regulates BDH1-mediated β-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells
Journal: Signal Transduction and Targeted Therapy
Year: 2021

Title: Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis
Journal: Advanced Materials
Year: 2022

Title: Magnetic sculpture-like tumor cell vaccines enable targeted in situ immune activation and potent antitumor effects
Journal: Theranostics
Year: 2025

Title: Vitamin D binding protein (VDBP) hijacks Twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma
Journal: Theranostics
Year: 2024

Conclusion

Dr. Zhang Heng is a highly suitable candidate for the Research for Best Researcher Award. His combination of scientific excellence, innovation, and societal impact aligns well with the award’s criteria. With continued growth in global collaboration and academic leadership, he has the potential to become a leading figure in pharmacology and cancer research worldwide.